Abstract
Amavata is most crippling joint disease . With the passage of time most of the dietary habits, changing lifestyle and environment have been contributing number of diseases like Amavata which have become a challenge to the human race. Management of this disease is merely insufficient in other systems of medicine and patients are continuously looking for treatment from Ayurveda to overcome this challenge. The aim of this study wa s to evaluate the efficacy of study drugs in the management of Amavata and their effect on Rheumatoid Factor ( RA ) Factor. In the present clinical study, 60 patients of amavata were registered from the out patient department and indoor patient department of Yashwant Dharmarth Hospital, Kodoli, Kolhapur , Maharashtra, India . The patients in group I (20 patients) were given Bhallatakadi Churna, patients in group II (20 patients) were given Eranda tail and the patients in group III (20 patients) were given Bhallatakadi Churna along with Eranda tail. P atients treated with group III had better relief in most of lakshanas of disease and also improvement in objecti ve criteria like RA Factor, ESR and C reac tive proteins. The improvement wa s statistically significant in all three groups, but comparatively group III shown more significant relief.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Research in Ayurveda & Pharmacy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
